Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

被引：0
|
作者：
Jean-François Yale
Taner Damci
Marcel Kaiser
Eddy Karnieli
Kamlesh Khunti
Andreas Liebl
Florian MM Baeres
Anne Louise Svendsen
Stuart A Ross
机构：
[1] Royal Victoria Hospital,McGill Nutrition and Food Science Centre
[2] Istanbul University,Department of Endocrinology, Cerrahpasa Medical School, Diabetes and Metabolism
[3] Practice for Internal Medicine and Diabetology,Endocrinology, Diabetes & Metabolism
[4] Rambam Medical Center and Rappaport Faculty of Medicine,Diabetes Research Centre
[5] University of Leicester,Center for Diabetes and Metabolism
[6] m&i-Fachklinik Bad Heilbrunn,undefined
[7] Global Medical Affairs,undefined
[8] Department of Biostatistics & Epidemiology,undefined
[9] University of Calgary,undefined
[10] the SOLVE Study Group,undefined
来源：
Diabetology & Metabolic Syndrome | / 5卷
关键词：
Type 2 diabetes mellitus; Insulin therapy; Weight; Body mass index; Insulin dose; Hypoglycaemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study
    Yale, Jean-Francois
    Damci, Taner
    Kaiser, Marcel
    Karnieli, Eddy
    Khunti, Kamlesh
    Liebl, Andreas
    Baeres, Florian M. M.
    Svendsen, Anne Louise
    Ross, Stuart A.
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [2] Study of Once-Daily Levemir (SOLVE™): Weight Changes Associated With the Initiation of Once-Daily Insulin Detemir in Chinese Patients With Type 2 Diabetes
    Pan, Changyu
    Ji, Qiuhe
    Li, Yanbing
    DIABETES, 2012, 61 : A612 - A612
  • [3] Treatment satisfaction in Type 2 diabetes patients starting once daily insulin detemir
    Smith, I. C.
    Hansen, J. B.
    DIABETIC MEDICINE, 2008, 25
  • [4] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [5] Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study
    Taner Damci
    Rifat Emral
    Anne Louise Svendsen
    Tanzer Balkir
    Jiten Vora
    BMC Endocrine Disorders, 14
  • [6] Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study
    Damci, Taner
    Emral, Rifat
    Svendsen, Anne Louise
    Balkir, Tanzer
    Vora, Jiten
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [7] Observational Study of Once-Daily Insulin Detemir in People with Type 2 Diabetes Aged 75 Years or Older
    Karnieli, Eddy
    Baeres, Florian M. M.
    Dzida, Grzegorz
    Ji, Qiuhe
    Ligthelm, Robert
    Ross, Stuart
    Svendsen, Anne Louise
    Yale, Jean-Francois
    DRUGS & AGING, 2013, 30 (03) : 167 - 175
  • [8] Once-daily insulin detemir added to oral antidiabetic drugs results in less weight gain and a trend for reduced hypoglycaemia in comparison to NPH insulin in Japanese patients with type 2 diabetes
    Tajima, N.
    Iwamoto, Y.
    Kaku, K.
    Kawamori, R.
    Nishida, T.
    Kobayashi, M.
    DIABETOLOGIA, 2006, 49 : 609 - 609
  • [9] Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: Subgroup analysis of the SOLVE study
    Pan, Changyu
    Han, Ping
    Ji, Linong
    Ji, Qiuhe
    Lu, Juming
    Lin, Jing
    Liu, Jie
    Su, Benli
    Shi, Jingmei
    Wang, Penghua
    JOURNAL OF DIABETES, 2015, 7 (02) : 222 - 230
  • [10] Weight change upon once-daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin-naive individuals with type 2 diabetes: results from the DIET trial
    Niswender, K.
    Piletic, M.
    Andersen, H.
    Hiort, L. Conradsen
    Hollander, P.
    DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 186 - 192
12345